Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does THIOTEPA Cause Graft versus host disease? 204 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 204 reports of Graft versus host disease have been filed in association with THIOTEPA (Thiotepa). This represents 3.0% of all adverse event reports for THIOTEPA.

204
Reports of Graft versus host disease with THIOTEPA
3.0%
of all THIOTEPA reports
110
Deaths
29
Hospitalizations

How Dangerous Is Graft versus host disease From THIOTEPA?

Of the 204 reports, 110 (53.9%) resulted in death, 29 (14.2%) required hospitalization, and 4 (2.0%) were considered life-threatening.

Is Graft versus host disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for THIOTEPA. However, 204 reports have been filed with the FAERS database.

What Other Side Effects Does THIOTEPA Cause?

Off label use (762) Febrile neutropenia (645) Mucosal inflammation (616) Cytomegalovirus infection (446) Product use in unapproved indication (425) Pyrexia (359) Drug ineffective (358) Acute graft versus host disease in skin (355) Acute graft versus host disease (331) Cytomegalovirus infection reactivation (325)

What Other Drugs Cause Graft versus host disease?

CYCLOSPORINE (1,131) TACROLIMUS (900) MYCOPHENOLATE MOFETIL (890) CYCLOPHOSPHAMIDE (653) METHOTREXATE (615) FLUDARABINE (541) BUSULFAN (507) RUXOLITINIB (469) METHYLPREDNISOLONE (429) PREDNISONE (405)

Which THIOTEPA Alternatives Have Lower Graft versus host disease Risk?

THIOTEPA vs THIOTHIXENE THIOTEPA vs THROMBIN THIOTEPA vs THROMBIN HUMAN THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS THIOTEPA vs THYMOGLOBULINE

Related Pages

THIOTEPA Full Profile All Graft versus host disease Reports All Drugs Causing Graft versus host disease THIOTEPA Demographics